<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02177994</url>
  </required_header>
  <id_info>
    <org_study_id>TOAPFECSACT</org_study_id>
    <secondary_id>AinShamsMH</secondary_id>
    <nct_id>NCT02177994</nct_id>
  </id_info>
  <brief_title>Antibiotic Prophylaxis for Elective Cesarean Section</brief_title>
  <acronym>TOAPFECSACT</acronym>
  <official_title>Timing of Antibiotic Prophylaxis for Elective Cesarean Section: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized controlled study comparing the effect of administration of 1 gm ceftriaxone in
      elective cesarean section 30-60 min before skin incision versus after cord clamping.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      comparing the effect of administration of 1 gm ceftriaxone in elective cesarean section 30-60
      min before skin incision versus after cord clamping.on post-cesarean section infection(wound
      infection as a primary outcome)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary outcome is the rate of post cesarean section surgical site infection.</measure>
    <time_frame>administration of 1gm ceftriaxone prophylaxis for elective cs and follow up surgical site infection till 40 days</time_frame>
    <description>postoperative assessment of SSI. Patients will be followed up at 48-72 hours postoperative, at 7th days (skin suture removal) and at 6 weeks (contraception application).all patients will be contacted by telephone and interviewed. They will be rescheduled for a clinic visit if they reported signs and symptoms of wound infection (purulent discharge or erythema &gt;1 cm in diameter, induration of the incision site and fever).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>other post cesarean section maternal and neonatal infection</measure>
    <time_frame>follow up ofother post cesarean section maternal and neonatal infection till 40 days of delivery</time_frame>
    <description>Maternal complications: other post cesarean section maternal complications, namely endometritis, pyrexia, urinary tract infection and complication of drug administration such as anaphylaxis.
Neonatal complications: such as neonatal sepsis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">328</enrollment>
  <condition>Infection of Cesarian Section Wound Following Delivery</condition>
  <arm_group>
    <arm_group_label>Group A ceftriaxone after cord clamping</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>165 patients pregnant at 37weeks or more undergoing elective cesarean section randomly distributed to receive
1 gm. ceftriaxone via l intravenous infusion single dose after cord clamping.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B ceftriaxone before skin incision</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>165 patients pregnant at 37weeks or more undergoing elective cesarean section randomly distributed to receive
1 gm. ceftriaxone vial intravenous infusion single dose 30-60 minutes before skin incision.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ceftriaxone 1gm for intravenous infusion</intervention_name>
    <description>Patients undergoing elective cesarean section with Gestational age 37 weeks or more. comparing the effect of administration of 1 gm ceftriaxone in elective cesarean section 30-60 min before skin incision versus after cord clamping.on post-cesarean section infection(wound infection as a primary outcome)</description>
    <arm_group_label>Group A ceftriaxone after cord clamping</arm_group_label>
    <arm_group_label>Group B ceftriaxone before skin incision</arm_group_label>
    <other_name>cefaxon</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing elective cesarean section with Gestational age 37 weeks or more

        Exclusion Criteria:

          1. Fever greater than 38Â°C or maternal sepsis.

          2. Cephalosporin allergy.

          3. Exposure to any antibiotic agent within 1week before delivery.

          4. Patents having premature rupture of membranes and acute chorioamnionitis.

          5. Patients with chronic diseases (diabetes mellitus, renal disease and Cardiac disease).

        3) Morbid obesity (BMI&gt;30)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amr AH Helmy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams Maternity Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Antibiotic Prophylaxis for Elective Cesarean Section</name>
      <address>
        <city>Cairo</city>
        <zip>+20</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2014</study_first_submitted>
  <study_first_submitted_qc>June 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2014</study_first_posted>
  <last_update_submitted>June 24, 2015</last_update_submitted>
  <last_update_submitted_qc>June 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>AMR HELMY YEHIA</investigator_full_name>
    <investigator_title>Lecturer in OB GYN</investigator_title>
  </responsible_party>
  <keyword>Elective Cesarean Section</keyword>
  <keyword>Antibiotic prophylaxis</keyword>
  <keyword>Timing of Antibiotic prophylaxis</keyword>
  <keyword>post cesarean section infection</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Ceftriaxone</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

